Comment SIEMENS met en œuvre le concept de sûreté dans les automatismes? = How does SIEMENS implement safeguard concept in automatisms?MYSLIWIEC, M.Travail et méthodes. 1991, Num 490, pp 41-47, issn 0041-185XArticle

THE EFFECT OF PHENFORMIN PLUS STANOZOLOL ON FIBRINOLYSIS, PLATELET ADHESIVENESS AND BLOOD LIPIDS IN PATIENTS WITH RECURRENT VENOUS THROMBOSIS = EFFET DE LA PHENFORMINE ASSOCIEE AU STANOZOLOL SUR LA FIBRINOLYSE, L'ADHESIVITE DES PLAQUETTES ET LES LIPIDES DU SANG CHEZ LES MALADES AVEC UNE THROMBOSE VEINEUSE RECIDIVANTEBIELAWIEC M; MYSLIWIEC M; PERZANOWSKI A et al.1974; FOLIA HAEMATOL.; ALLEM.; DA. 1974; VOL. 101; NO 3; PP. 483-488; ABS. ALLEM. FR. RUSSE; BIBL. 1P.Article

OZNACZENIE FORMALDEHYDU W ZYWICACH AMINOWYCH NIEROZPUSZCZALNYCH W WODZIE = DETERMINATION DU FORMALDEHYDE DANS LES RESINES AMINEES INSOLUBLES DANS L'EAUMAJNUSZ MYSLIWIEC M; GLOSNICKA M; NOWAK D et al.1981; POLIMERY; ISSN 0032-2725; POL; DA. 1981; VOL. 26; NO 10; PP. 388-391; BIBL. 11 REF.Article

DECREASED PLASMINOGEN ACTIVATOR BUT NORMAL PROSTACYCLIN ACTIVITY IN RAT VEINS DURING DEVELOPMENT OF EXPERIMENTAL THROMBOSISMYSLIWIEC M; VILLA S; KORNBLIHTT L et al.1980; THROMBOSIS RES.; GBR; DA. 1980; VOL. 18; NO 1-2; PP. 159-165; BIBL. 21 REF.Article

THE INFLUENCE OF AZATHIOPRINE ON THE BEHAVIOUR OF BLOOD PLATELETS IN VITRO.BOGDANIKOWA B; MYSLIWIEC M; BIELAWIEC M et al.1976; FOLIA HAEMATOL.; ALLEM.; DA. 1976; VOL. 103; NO 2; PP. 248-251; ABS. ALLEM. FR. RUSSE; BIBL. 12 REF.Article

UNTERSUCHUNGEN UEBER DEN ¹³¹I-FIBRINOGENUMSATZ BEI DER AKTIVIERUNG DER BLUTFIBRINOLYSE. = ETUDES DE LA TRANSFORMATION DU FIBRINOGENE AU I 131 DANS L'ACTIVATION DE LA FIBRINOLYSE SANGUINEGRABOWSKI R; BIELAWIEC M; KIERSNOWSKA B et al.1976; Z. GES. INNERE MED.; DTSCH.; DA. 1976; VOL. 31; NO 24; PP. 1025-1027; ABS. RUSSE ANGL.; BIBL. 11 REF.Article

Thyroid function and morphology in kidney transplant recipients, hemodialyzed, and peritoneally dialyzed patientsŁEBKOWSKA, U; MALYSZKO, J; MYSLIWIEC, M et al.Transplantation proceedings. 2003, Vol 35, Num 8, pp 2945-2948, issn 0041-1345, 4 p.Article

Ketanserin lowers erythropoietin concentration in hemodialyzed patients treated with the hormoneBORAWSKI, J; MAZERSKA, M; PAWLAK, K et al.Journal of cardiovascular pharmacology. 1995, Vol 26, Num 4, pp 621-626, issn 0160-2446Article

A Possible Role of Hepcidin in the Pathogenesis of Anemia Among Kidney Allograft RecipientsMALYSZKO, J; MALYSZKO, J. S; MYSLIWIEC, M et al.Transplantation proceedings. 2009, Vol 41, Num 8, pp 3056-3059, issn 0041-1345, 4 p.Conference Paper

Normal response of uraemic platelets to thromboxane A₂ agonistSOSZKA, J; RYDZEWSKI, A; MYSLIWIEC, M et al.Nephron. 1983, Vol 35, Num 4, pp 267-268, issn 0028-2766Article

Treatment of Anemia With Erythropoietin-Stimulating Agents in Kidney Transplant Recipients and Chronic Kidney Disease—Another Drawback of Immunosuppression?MALYSZKO, J; GLOWINSKA, I; MYSLIWIEC, M et al.Transplantation proceedings. 2012, Vol 44, Num 10, pp 3013-3016, issn 0041-1345, 4 p.Article

Desmopressin induces decrease in platelet count in uremiaRYDZEWSKI, A; ROWINSKI, M; MYSLIWIEC, M et al.Thrombosis and haemostasis. 1986, Vol 55, Num 3, issn 0340-6245, 436Article

Odpad z rafinacji benzolu koksowniczego-badania nad bezpiecznym wprowadzaniem do środowiska = Investigation of safe introduction of wastes from benzol refining into environmentMAJNUSZ-MYSLIWIEC, M; TERAKOWSKI, M; GORNIG, D et al.Karbo (Warszawa). 1993, Vol 38, Num 5, pp 95-100, issn 1230-0446Article

Concentration of three thrombin inhibitors in the nephrotic syndrome in adultsRYDZEWSKI, A; MYSLIWIEC, M; SOSZKA, J et al.Nephron. 1986, Vol 42, Num 3, pp 200-203, issn 0028-2766Article

Endogenous neurotoxine-quinolinic acid is increased in renal allograft recipientsMYSLIWIEC, P; PAWLAK, D; MYSLIWIEC, M et al.Transplantation proceedings. 2002, Vol 34, Num 2, pp 598-600, issn 0041-1345Conference Paper

Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndromeMALYSZKO, J; MALYSZKO, J. S; MYSLIWIEC, M et al.Blood coagulation & fibrinolysis. 2002, Vol 13, Num 7, pp 615-621, issn 0957-5235, 7 p.Article

Thyroid gland function in patients after renal transplantationŁEBKOWSKA, U; MATYSZKO, J; BRZOSKO, S et al.Transplantation proceedings. 2002, Vol 34, Num 2, pp 596-597, issn 0041-1345Conference Paper

Kidney Injury Molecule-1 Correlates With Kidney Function in Renal Allograft RecipientsMALYSZKO, J; KOC-ZORAWSKA, E; MALYSZKO, J. S et al.Transplantation proceedings. 2010, Vol 42, Num 10, pp 3957-3959, issn 0041-1345, 3 p.Conference Paper

Aluminium and beta-2-microglobulin in kidney transplant recipientsMAŁYSZKO, J; WOŁCZYNSKI, S; MAŁYSZKO, J. S et al.Transplantation proceedings. 2002, Vol 34, Num 2, pp 580-582, issn 0041-1345Conference Paper

Hepcidin, an acute-phase protein and a marker of inflammation in kidney transplant recipients with and without coronary artery diseaseMALYSZKO, J; MALYSZKO, J. S; PAWLAK, K et al.Transplantation proceedings. 2006, Vol 38, Num 9, pp 2895-2898, issn 0041-1345, 4 p.Article

Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipientsMALYSZKO, J; MALYSZKO, J. S; WOLCZYNSKI, S et al.Transplantation proceedings. 2003, Vol 35, Num 6, pp 2227-2229, issn 0041-1345, 3 p.Conference Paper

Thrombin-activatable fibrinolysis inhibitor in kidney transplant recipient with dyslipidemiaMALYSZKO, J; MALYSZKO, J. S; HRYSZKO, T et al.Transplantation proceedings. 2003, Vol 35, Num 6, pp 2219-2221, issn 0041-1345, 3 p.Conference Paper

Correlations between new markers of bone formation versus bone resorption in kidney transplant recipientsMAŁYSZKO, J; WOŁCZYNSKI, S; MAŁYSZKO, J. S et al.Transplantation proceedings. 2002, Vol 34, Num 2, pp 591-592, issn 0041-1345Conference Paper

The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipientsMALYSZKO, J; MALYSKO, J. S; PAWLAK, K et al.Transplantation. 1996, Vol 62, Num 6, pp 828-830, issn 0041-1337Article

Some aspects of hemostasis in kidney transplant recipients maintained on cyclosporine, azathioprine, and prednisone in comparison to patients treated with cyclosporine and prednisoneMALYSZKO, J; MALYSZKO, J. S; HRYSZKO, T et al.Transplantation proceedings. 2003, Vol 35, Num 8, pp 2940-2942, issn 0041-1345, 3 p.Article